Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection
Conditions:   Leukemia,;   Allogeneic Stem Cell TransplantationIntervention:   Drug: Caspofugin  based combination therapySponsor:   Shanghai Jiao Tong University School of MedicineRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 26, 2011 Category: Research Source Type: clinical trials

Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions:   Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Minimally Differentiated Myeloid Leukemia (M0);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q); &...
Source: ClinicalTrials.gov - March 1, 2011 Category: Research Source Type: clinical trials

A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)
Conditions:   Candidiasis, Esophageal;   Candidiasis, Invasive;   AspergillosisIntervention:   Drug: CaspofunginSponsor:   Merck Sharp & Dohme Corp.Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2010 Category: Research Source Type: clinical trials

A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
Condition:   Fungal InfectionInterventions:   Drug: caspofungin acetate;   Drug: Comparator:  Micafungin sodiumSponsor:   Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2008 Category: Research Source Type: clinical trials

A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
Condition:   Fungal InfectionInterventions:   Drug: caspofungin acetate;   Drug: Comparator:  Micafungin sodiumSponsor:   Merck Sharp & Dohme Corp.Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2008 Category: Research Source Type: clinical trials

A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)
Condition:   Fungal InfectionIntervention:   Drug: caspofungin acetateSponsor:   Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2008 Category: Research Source Type: clinical trials

A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)
Condition:   Fungal InfectionIntervention:   Drug: caspofungin acetateSponsor:   Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2008 Category: Research Source Type: clinical trials

Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)
Condition:   Fungal InfectionIntervention:   Drug: MK0991, caspofungin acetate / Duration of Treatment:Sponsor:   Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2007 Category: Research Source Type: clinical trials

Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
Conditions:   Mycoses;   Candidiasis, Invasive;   CandidemiaInterventions:   Drug: Isavuconazole;   Drug: Caspofungin;   Drug: VoriconazoleSponsors:   Astellas Pharma Inc;   Basilea PharmaceuticaActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2006 Category: Research Source Type: clinical trials

Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
Conditions:   Mycoses;   Candidiasis, Invasive;   CandidemiaInterventions:   Drug: Isavuconazole;   Drug: Caspofungin;   Drug: VoriconazoleSponsors:   Astellas Pharma Inc;   Basilea PharmaceuticaCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2006 Category: Research Source Type: clinical trials

A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED)
Condition:   Fungal InfectionIntervention:   Drug: caspofungin acetateSponsor:   Merck Sharp & Dohme Corp.Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2006 Category: Research Source Type: clinical trials

Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)
Condition:   CandidiasisIntervention:   Drug: MK0991, caspofungin acetate/Duration of Treatment: variableSponsor:   Merck Sharp & Dohme Corp.Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 20, 2004 Category: Research Source Type: clinical trials